NEW YORK (GenomeWeb) – Thermo Fisher Scientific said on Tuesday that it has priced an offering of €2.6 billion ($3 billion) of senior notes.

The notes include €500 million of floating rate senior notes due 2019, issued at 100.205 percent of their principal amount; €700 million of 1.4 percent senior notes due 2026, issued at 99.526 percent of their principal amount; €700 million of 1.95 percent senior notes due 2029, issued at 99.282 percent of their principal amount; and €700 million of 2.875 percent senior notes due 2037, issued at 99.76 percent of their principal amount.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.